JNJ Shares of Johnson & Johnson are up more than 2% after the Healthcare giant agreed to pay $5.5B to settle thousands of lawsuits alleging

JNJ Shares of Johnson & Johnson are up more than 2% after the Healthcare giant agreed to pay $5.5B to settle thousands of lawsuits alleging some of its talc products caused ovarian cancer. Club holding J&j said the claims were "meritless" but was willing to put the decade-long matter behind it. - per Cramer Investing Club Newsletter